Hormone-hormone receptor complexes and nucleic acid constructs and their use in gene therapy

Details for Australian Patent Application No. 2005200908 (hide)

Owner Octagene GmbH

Inventors Hauser-Funke, Charlotte

Agent Davies Collison Cave

Pub. Number AU-A-2005200908

Parent 780854

Filing date 28 February 2005

Wipo publication date 24 March 2005

International Classifications

C12N 015/12 Mutation or genetic engineering - Genes encoding animal proteins

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

C12Q 001/68 Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

C07K 014/72 Peptides having more than 20 amino acids

C12N 009/64 Enzymes, e.g. ligases (6.) - derived from animal tissue, e.g. rennin

C12N 015/85 Mutation or genetic engineering - for animal cells

C12N 015/67 Mutation or genetic engineering - General methods for enhancing the expression

C12N 015/57 Mutation or genetic engineering - acting on peptide bonds (3.4)

Event Publications

17 March 2005 Complete Application Filed

24 March 2005 Application Open to Public Inspection

  Published as AU-A-2005200908

21 September 2006 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005200909-Antimicrobial composition containing N- (n-butyl)-1,2-benzisothiazolin-3-one

2005200907-Formulation for menopausal women